The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon

REFERENCES

1. 1.↵
   1. Pope J.

   Raynaud’s phenomenon (primary). BMJ Clin Evid 2013;2013:1119.

   OpenUrlPubMed
2. 2.↵
   1. Wigley FM,
   2. Flavahan NA.

   Raynaud’s phenomenon. N Engl J Med 2016;375:556-65.

   OpenUrlPubMed
3. 3.↵
   1. Block JA,
   2. Sequeira W.

   Raynaud’s phenomenon. Lancet 2001;357:2042-8.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Herrick A.

   Raynaud’s phenomenon (secondary). BMJ Clin Evid 2008;2008:1125.

   OpenUrlPubMed
5. 5.↵
   1. Scolnik M,
   2. Vasta B,
   3. Hart DJ,
   4. Shipley JA,
   5. McHugh NJ,
   6. Pauling JD.

   Symptoms of Raynaud’s phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology. Rheumatol Int 2016;36:1371-7.

   OpenUrlPubMed
6. 6.
   1. Shukla R,
   2. Liu C,
   3. Wilkinson S,
   4. Gosal D,
   5. Herrick AL.

   Prevalence of Raynaud’s phenomenon in patients with peripheral neuropathy. J Scleroderma Relat Disord 2023;8:253-4.

   OpenUrlPubMed
7. 7.
   1. Miest RY,
   2. Comfere NI,
   3. Dispenzieri A,
   4. Lohse CM,
   5. El-Azhary RA.

   Cutaneous manifestations in patients with POEMS syndrome. Int J Dermatol 2013;52:1349-56.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Musa R,
   2. Qurie A.

   Raynaud Disease. [Updated 2023 Aug 8]. In: StatPearls [Internet. Accessed June 5, 2025.] Treasure Island, FL: StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499833/
9. 9.↵
   1. Ingegnoli F,
   2. Ughi N,
   3. Crotti C,
   4. Mosca M,
   5. Tani C.

   Outcomes, rates and predictors of transition of isolated Raynaud’s phenomenon: a systematic review and meta-analysis. Swiss Med Wkly 2017;147:w14506.

   OpenUrlPubMed
10. 10.↵
    1. van den Hoogen F,
    2. Khanna D,
    3. Fransen J, et al

    . 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.

    OpenUrlCrossRefPubMed